Recombinant multi-species SDF2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SDF2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene is believed to be a secretory protein. It has regions of similarity to hydrophilic segments of yeast mannosyltransferases. Its expression is ubiquitous and the gene appears to be relatively conserved among mammals. Alternate splicing results in both coding and non-coding variants. A pseudogene of this gene is located on chromosome 15. [provided by RefSeq, Dec 2011]
The Alternative Names of target: SDF-2,SDF2,Sdf2,Stromal cell-derived factor 2

Target products collectionGo to SDF2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-SE1498-Ag-1/ GM-Tg-hg-SE1498-Ag-2 Human SDF2 protein Human
GM-Tg-rg-SE1498-Ag-1/ GM-Tg-rg-SE1498-Ag-2 Rat SDF2 protein Rat
GM-Tg-mg-SE1498-Ag-1/ GM-Tg-mg-SE1498-Ag-2 Mouse SDF2 protein Mouse
GM-Tg-cynog-SE1498-Ag-1/ GM-Tg-cynog-SE1498-Ag-2 Cynomolgus/Rhesus macaque SDF2 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-SE1498-Ag-1/ GM-Tg-felg-SE1498-Ag-2 Feline SDF2 protein Feline
GM-Tg-cang-SE1498-Ag-1/ GM-Tg-cang-SE1498-Ag-2 Canine SDF2 protein Canine
GM-Tg-bovg-SE1498-Ag-1/ GM-Tg-bovg-SE1498-Ag-2 Bovine SDF2 protein Bovine
GM-Tg-equg-SE1498-Ag-1/ GM-Tg-equg-SE1498-Ag-2 Equine SDF2 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-SE1498-Ag-1/ GM-Tg-hg-SE1498-Ag-2; GM-Tg-rg-SE1498-Ag-1/ GM-Tg-rg-SE1498-Ag-2;
GM-Tg-mg-SE1498-Ag-1/ GM-Tg-mg-SE1498-Ag-2; GM-Tg-cynog-SE1498-Ag-1/ GM-Tg-cynog-SE1498-Ag-2;
GM-Tg-felg-SE1498-Ag-1/ GM-Tg-felg-SE1498-Ag-2; GM-Tg-cang-SE1498-Ag-1/ GM-Tg-cang-SE1498-Ag-2;
GM-Tg-bovg-SE1498-Ag-1/ GM-Tg-bovg-SE1498-Ag-2; GM-Tg-equg-SE1498-Ag-1/ GM-Tg-equg-SE1498-Ag-2
Products Name SDF2 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name SDF2
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SDF2 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.